Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced       Help   


 The Delphion Integrated View: INPADOC Record

  Buy Now:   Buy PDF  PDF  |   File History  |   Other choices   
  Tools:  Add to Work File:    
  View:  Jump to: 
 
 Email this to a friend  Email this to a friend 
       
Title: FR2674753A1: NOUVELLES INDICATIONS THERAPEUTIQUES, EN PARTICULIER POUR LE TRAITEMENT DU SIDA, D'UN MEDICAMENT DEJA EXISTANT ET FABRIQUE A PARTIR D'UNE MOLECULE DENUEE DE CONTRE-INDICATIONS ET D'EFFETS INDESIRABLES.
[ Derwent Title ]


Country:
Kind:
FR France
A1 APPLICATION FOR PATENT OF INVENTION, (FIRST PUBL.) [FROM # 2000000] i (See also: FR2674753B1 )

 View Images  High
Resolution

 
 
Inventor: JEAN BERQUE;

Assignee: BERQUE JEAN
 News, Profiles, Stocks and More about this company

Published / Filed: 1992-10-09 / 1991-04-02

Application Number: FR1991000004218

IPC Code: Advanced: A61K 31/519; A61K 31/525; A61K 31/70; A61P 31/12; A61P 31/18; A61P 31/22; A61P 33/02; A61P 37/04; C07D 475/14;

ECLA Code: A61K31/525; A61K31/70;

Priority Number:
1991-04-02  FR1991000004218

Abstract:     The use of riboflavin or vitamin B2 for treating HIV-related diseases, herpes, retinitis pigmentosa and malaria is described. This molecule may be combined with vitamin PP or with AZT for treating HIV-related diseases. Clinical trials have shown a remission of herpes symptoms and an improvement in the condition of patients suffering from AIDS. [French]

INPADOC Legal Status:
Gazette date Code   Description (remarks)     List all possible codes for FR
2011-01-21 ST - Notification of lapse   ( 2010-12-30 )

  
Buy Now: Family Legal Status Report

Designated Country: AU BR CA CS EP FI HU JP NO OA PL RO RU US 

       
Family:
Buy
PDF
PublicationPub. DateFiled   Assignee   Title
Buy PDF WO9217173A3 1993-01-07  1992-04-02  BERQUE JEAN USE OF RIBOFLAVIN FOR TREATING HIV-RELATED DISEASES, HERPES, RETINITIS PIGMENTOSA AND MALARIA
Buy PDF - 12pp WO9217173A2 1992-10-15  1992-04-02  BERQUE, Jean USE OF RIBOFLAVIN FOR TREATING HIV-RELATED DISEASES, HERPES, RETINITIS PIGMENTOSA AND MALARIA
Buy PDF OA0009819A 1994-04-15  1993-10-01  BERQUE JEAN Utilisation de la riboflavine dans le taitement de maladies liées aux virus hiv de l'herpès de la rétinite pigmentaire et du paludisme
Buy PDF JP06506212T2 1994-07-14  1992-04-02     
Buy PDF FR2715303A1 1995-07-28  1994-12-06  BERQUE JEAN Riboflavin for treating human immunodeficiency virus related diseases
Buy PDF FR2674753B1 1995-03-10  1991-04-02  BERQUE JEAN NOUVELLES INDICATIONS THERAPEUTIQUES, EN PARTICULIER POUR LE TRAITEMENT DU SIDA, D'UN MEDICAMENT DEJA EXISTANT ET FABRIQUE A PARTIR D'UNE MOLECULE DENUEE DE CONTRE-INDICATIONS ET D'EFFETS INDESIRABLES.
Buy PDF FR2674753A1 1992-10-09  1991-04-02  BERQUE JEAN NOUVELLES INDICATIONS THERAPEUTIQUES, EN PARTICULIER POUR LE TRAITEMENT DU SIDA, D'UN MEDICAMENT DEJA EXISTANT ET FABRIQUE A PARTIR D'UNE MOLECULE DENUEE DE CONTRE-INDICATIONS ET D'EFFETS INDESIRABLES.
Buy PDF EP0578733A1 1994-01-19  1992-04-02  BERQUE, Jean USE OF RIBOFLAVIN IN THE TREATMENT OF HIV, HERPES VIRUS, RETINITIS PIGMENTOSA AND MALARIA RELATED DESEASES
  CA2107078AA        
Buy PDF CA2107078A1 1992-10-03  1992-04-02  BERQUE JEAN USE OF RIBOFLAVIN IN THE TREATMENT OF HIV-LINKED DISEASES, HERPES, RETINITIS PIGMENTOSA AND MALARIA
Buy PDF AU1654092A1 1992-11-02  1992-04-02  JEAN BERQUE USE OF RIBOFLAVIN FOR TREATING HIV-RELATED DISEASES, HERPES, RETINITIS PIGMENTOSA AND MALARIA
  11 family members shown above


       
Forward References: Go to Result Set: Forward references (13)
Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 26pp US7985588  2011-07-26 Goodrich; Raymond P.  CaridianBCT Biotechnologies, LLC Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
Buy PDF- 18pp US7901673  2011-03-08 Lockerbie; Robert Owen  CaridianBCT Biotechnologies, LLC Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
Buy PDF- 19pp US7892535  2011-02-22 Goodrich; Raymond P.  CaridianBCT Biotechnologies, LLC Preventing transfusion related complications in a recipient of a blood transfusion
Buy PDF- 19pp US7648699  2010-01-19 Goodrich; Raymond P.  CaridianBCT Biotechnologies, LLC Preventing transfusion related complications in a recipient of a blood transfusion
Buy PDF- 21pp US7498156  2009-03-03 Goodrich; Raymond P.  CaridianBCT Biotechnologies, LLC Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
Buy PDF- 41pp US7220747  2007-05-22 Dumont; Larry Joe  Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
Buy PDF- 70pp US7094378  2006-08-22 Goodrich, Jr.; Raymond Paul  Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
Buy PDF- 29pp US7049110  2006-05-23 Reddy; Heather  Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
Buy PDF- 20pp US6828323  2004-12-07 Platz; Matthew Stewart  Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
Buy PDF- 39pp US6548241  2003-04-15 McBurney; Laura  Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
Buy PDF- 42pp US6277337  2001-08-21 Goodrich, Jr.; Raymond Paul  Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
Buy PDF- 17pp US6268120  2001-07-31 Platz; Matthew Stewart  Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
Buy PDF- 23pp US6258577  2001-07-10 Goodrich, Jr.; Raymond Paul  Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
       
Other Abstract Info: None

Inquire Regarding Licensing

Powered by Verity


Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

Thomson Reuters Copyright © 1997-2014 Thomson Reuters 
Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help